The ECTRIMS Podcast
By The European Committee for Treatment and Research in Multiple Sclerosis
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 78
Description
The ECTRIMS Podcast is a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
| Episode | Date |
|---|---|
|
MS Research Briefs: MRI Biomarkers, Machine Learning and the Future of MS Diagnosis
|
Jul 02, 2026 |
|
Vitamin D and Multiple Sclerosis: Separating Evidence from Expectation
|
Jun 18, 2026 |
|
Can the revised 2024 McDonald Diagnostic criteria solve the misdiagnosis problem in multiple sclerosis?
|
Jun 03, 2026 |
|
EBV and Multiple Sclerosis: Could Infection Hold the Key to MS?
|
May 15, 2026 |
|
Fenebrutinib in Relapsing MS: FENhance Trial Results Explained
|
Apr 22, 2026 |
|
How MRI and OCT are Changing Multiple Sclerosis Diagnosis, Prognosis, and Treatment
|
Apr 08, 2026 |
|
Does the Label Given to My MS Disease Course Matter?
|
Mar 19, 2026 |
|
Rehabilitation in MS and the Case for Early Intervention
|
Feb 25, 2026 |
|
Fenebrutinib in PPMS: Insights from ACTRIMS Forum 2026
|
Feb 07, 2026 |
|
Harnessing the Gut Microbiome in MS: From Insight to Intervention
|
Jan 13, 2026 |
|
How well are we measuring cognition in MS?
|
Dec 08, 2025 |
|
MS Nursing: Listening, Leadership, and the Role of AI in Patient Care
|
Nov 13, 2025 |
|
Why We Need to Talk More About Mental Health in MS
|
Oct 29, 2025 |
|
Patient Community Day 2025
|
Oct 15, 2025 |
|
Positive Remyelination Trial Results: Late Breaking at ECTRIMS 2025
|
Oct 02, 2025 |
|
Final Day Highlights of ECTRIMS 2025
|
Sep 26, 2025 |
|
Day 2 Highlights of ECTRIMS 2025
|
Sep 25, 2025 |
|
Day 1 Highlights of ECTRIMS 2025
|
Sep 24, 2025 |
|
Pre-Day Highlights of ECTRIMS 2025
|
Sep 23, 2025 |
|
2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know
|
Sep 19, 2025 |
|
Genetics and MS: Recent Discoveries and Future Directions
|
Sep 08, 2025 |
|
The Expanding Role of Patient-Reported Outcomes in MS Research
|
Jul 17, 2025 |
|
Biomarkers in MS
|
Jun 12, 2025 |
|
BTK Inhibitors: The Tolebrutinib Trial Results
|
May 21, 2025 |
|
The Role of Diet in Managing MS
|
Apr 24, 2025 |
|
Autologous Haematopoietic Stem Cell Transplantation for MS
|
Mar 27, 2025 |
|
How Real-World Data Is Shaping MS Treatment
|
Feb 20, 2025 |
|
Fatigue in Multiple Sclerosis
|
Jan 16, 2025 |
|
Advancing MS Knowledge through the ECTRIMS Fellowship
|
Dec 23, 2024 |
|
Addressing Diversity in MS Research and Care
|
Dec 12, 2024 |
|
Paediatric Multiple Sclerosis
|
Nov 27, 2024 |
|
MS Prodrome: Implications and Future Research Directions
|
Nov 07, 2024 |
|
Episode 37: Future MS Therapeutics
|
Oct 24, 2024 |
|
MS Nurses at ECTRIMS 2024
|
Oct 10, 2024 |
|
Patient Community Day Highlights of ECTRIMS 2024: Part II
|
Oct 09, 2024 |
|
Patient Community Day Highlights of ECTRIMS 2024: Part I
|
Oct 03, 2024 |
|
Day 3 Highlights of ECTRIMS 2024
|
Sep 20, 2024 |
|
Day 2 Highlights of ECTRIMS 2024
|
Sep 19, 2024 |
|
Day 1 Highlights of ECTRIMS 2024
|
Sep 18, 2024 |
|
Pre-Day Highlights of ECTRIMS 2024
|
Sep 17, 2024 |
|
Episode 35: NMOSD and MOGAD Part II
|
Sep 10, 2024 |
|
Episode 35: NMOSD and MOGAD Part I
|
Sep 10, 2024 |
|
ECTRIMS-EAN Vaccination Consensus Statement (eanCast)
|
Sep 04, 2024 |
|
Environmental, Genetic, and Epigenetic Risk Factors in MS
|
Aug 15, 2024 |
|
Myelin plasticity and repair
|
Jul 23, 2024 |
|
Lifestyle Modifications in MS
|
Jun 25, 2024 |
|
The Impact of Ageing on MS
|
Jun 05, 2024 |
|
Artificial Intelligence in MS Research
|
May 16, 2024 |
|
Prioritising Women's Health Topics in MS Research
|
Apr 20, 2024 |
|
Spotlight on Young MS Researchers
|
Mar 29, 2024 |
|
MS in the Black Community
|
Mar 07, 2024 |
|
Efforts Towards a Better MS Diagnostic Criteria
|
Feb 13, 2024 |
|
Factoring in Female Health in the MS Journey
|
Jan 31, 2024 |
|
The Importance of Patient Community Day
|
Jan 11, 2024 |
|
Genetics and MS Severity
|
Dec 15, 2023 |
|
Defining MS Subtypes in Clinical Practice
|
Nov 30, 2023 |
|
The Changing Role of MS Nurses
|
Nov 15, 2023 |
|
Discontinuing DMTs in Patients with Stable Relapsing-remitting MS: When and How?
|
Nov 10, 2023 |
|
Day Three Highlights of MSMilan2023
|
Oct 13, 2023 |
|
Day Two Highlights of MSMilan2023
|
Oct 12, 2023 |
|
Day One Highlights of MSMilan2023
|
Oct 11, 2023 |
|
Behind the landmark WHO decision on essential medicines for MS
|
Sep 21, 2023 |
|
Women with MS
|
Aug 10, 2023 |
|
Utilising Global Data Registries for MS Research
|
Jun 29, 2023 |
|
Epstein-Barr Virus and Multiple Sclerosis
|
May 24, 2023 |
|
Access For All: Adding MS DMTs to the WHO Essential Medicines List
|
Apr 12, 2023 |
|
Using Real-World Studies to Compare DMTs in MS
|
Mar 29, 2023 |
|
Remyelination in MS: a New Clinical Trial
|
Mar 06, 2023 |
|
Stem Cell Research in Multiple Sclerosis
|
Jan 24, 2023 |
|
ECTRIMS 2022 For People with MS: Part 3
|
Dec 28, 2022 |
|
ECTRIMS 2022 For People with MS: Part 2
|
Dec 21, 2022 |
|
ECTRIMS 2022 For People with MS: Part 1
|
Dec 17, 2022 |
|
Rethinking how different types of MS are described
|
Nov 19, 2022 |
|
The role of the MS nurse & the need for more globally: an ECTRIMS 2022 recap
|
Nov 16, 2022 |
|
ECTRIMS 2022 Wrap-up
|
Oct 29, 2022 |
|
Day Two Highlights of ECTRIMS 2022
|
Oct 28, 2022 |
|
Day One Highlights of ECTRIMS 2022
|
Oct 27, 2022 |
|
NEW! The ECTRIMS Podcast
|
Oct 17, 2022 |